Lyra Therapeutics, Inc.6月4日成交额为1662.14万美元

市场透视2025-06-05

美东时间2025年6月4日，Lyra Therapeutics, Inc.（LYRA.US）成交额为1662.14万美元，成交额较昨日减少90.27%，当日成交量为69.48万股。Lyra Therapeutics, Inc.（LYRA.US）于2025年6月4日跌17.26%，报22.82美元，该股过去5个交易日涨419.82%，年初至今涨121.55%，过去60日涨149.4%。|近5个交易日...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2541014599?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-06-05 10:53","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2541014599","market":"us","top_or_hot":-1,"title":"Lyra Therapeutics, Inc.6月4日成交额为1662.14万美元","media":"市场透视","content":"<div>\n<p>美东时间2025年6月4日，Lyra Therapeutics, Inc.（LYRA.US）成交额为1662.14万美元，成交额较昨日减少90.27%，当日成交量为69.48万股。Lyra Therapeutics, Inc.（LYRA.US）于2025年6月4日跌17.26%，报22.82美元，该股过去5个交易日涨419.82%，年初至今涨121.55%，过去60日涨149.4%。|近5个交易日...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605105313a49ab701&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lyra Therapeutics, Inc.6月4日成交额为1662.14万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLyra Therapeutics, Inc.6月4日成交额为1662.14万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-06-05 10:53 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605105313a49ab701&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>美东时间2025年6月4日，Lyra Therapeutics, Inc.（LYRA.US）成交额为1662.14万美元，成交额较昨日减少90.27%，当日成交量为69.48万股。Lyra Therapeutics, Inc.（LYRA.US）于2025年6月4日跌17.26%，报22.82美元，该股过去5个交易日涨419.82%，年初至今涨121.55%，过去60日涨149.4%。|近5个交易日...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605105313a49ab701&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605105313a49ab701&s=b","article_id":"2541014599","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605105313a49ab701&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2541014599","pubTimestamp":1749091985,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"美东时间2025年6月4日，Lyra Therapeutics, Inc.成交额为1662.14万美元，成交额较昨日减少90.27%，当日成交量为69.48万股。Lyra Therapeutics, Inc.于2025年6月4日跌17.26%，报22.82美元，该股过去5个交易日涨419.82%，年初至今涨121.55%，过去60日涨149.4%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-04|1662.14万|-90.27%|69.48万|#|2025-06-03|1.71亿|-77.04%|611.82万|#|2025-06-02|7.44亿|255783.30%|2685.68万|#|2025-05-30|29.09万|-45.07%|6.03万|#|2025-05-29|52.95万|-4.27%|10.79万|Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于开发和商业化针对患者的局部治疗的创新的药物与递送一体化解决方案。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4007":"制药","LENZ":"Therapeutics","BK4539":"次新股","LYRA":"Lyra Therapeutics","BK4139":"生物科技"},"translate_title":"Lyra Therapeutics, Inc. turnover of $16.6214 million on June 4","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LYRA":1,"LENZ":1},"content_text":"美东时间2025年6月4日，Lyra Therapeutics, Inc.（LYRA.US）成交额为1662.14万美元，成交额较昨日减少90.27%，当日成交量为69.48万股。Lyra Therapeutics, Inc.（LYRA.US）于2025年6月4日跌17.26%，报22.82美元，该股过去5个交易日涨419.82%，年初至今涨121.55%，过去60日涨149.4%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-04|1662.14万|-90.27%|69.48万|#|2025-06-03|1.71亿|-77.04%|611.82万|#|2025-06-02|7.44亿|255783.30%|2685.68万|#|2025-05-30|29.09万|-45.07%|6.03万|#|2025-05-29|52.95万|-4.27%|10.79万|Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于开发和商业化针对患者的局部治疗的创新的药物与递送一体化解决方案。公司的运营和业务管理作为一个单一的运营部门，即开发针对耳、鼻、喉（ENT）疾病的靶向药物。其初步产品候选物 LYR-210 和 LYR-220 是生物可吸收聚合物基质，旨在通过简短、非侵入性、在诊所进行的操作给药，并计划持续向鼻窦通道递送药物，以治疗慢性鼻窦炎（CRS）。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2541014599","isCrawlerRequest":true}